Old Web
English
Sign In
Acemap
>
authorDetail
>
Vivian Dai
Vivian Dai
Ibrutinib
Internal medicine
Medicine
Oncology
hodgkin lymphoma
4
Papers
3
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Poster: ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results
2021
Clinical Lymphoma, Myeloma & Leukemia
Murali Janakiram
Julien Depaus
Nina D. Wagner-Johnston
Pier Luigi Zinzani
Tycel J. Phillips
Joseph Maly
Silvia Ferrari
Locke J Bryan
Vincent Delwail
Sophie de Guibert
Monica Tani
Vivian Dai
Karin Havenith
Joseph Boni
Xiaomin He
Annette Ervin-Haynes
Carmelo Carlo-Stella
Show All
Source
Cite
Save
Citations (0)
CLINICAL ACTIVITY OF LONCASTUXIMAB TESIRINE PLUS IBRUTINIB IN NON-HODGKIN LYMPHOMA: UPDATED LOTIS 3 PHASE 1 RESULTS
2021
Hematological Oncology
Julien Depaus
Nina Wagner-Johnston
P. L. Zinzani
Tycel J. Phillips
Joseph Maly
Silvia Ferrari
E. Bachy
Locke J. Bryan
Vincent Delwail
Murali Janakiram
S. de Guibert
Monica Tani
Vivian Dai
Karin Havenith
Joseph Boni
Xiaomin He
Annette Ervin-Haynes
C. Carlo-Stella
Show All
Source
Cite
Save
Citations (2)
ABCL-339: Clinical Activity of Loncastuximab Tesirine (Lonca) Plus Ibrutinib in Non-Hodgkin Lymphoma: Updated LOTIS-3 Phase 1 Results
2021
Clinical Lymphoma, Myeloma & Leukemia
Murali Janakiram
Julien Depaus
Nina Wagner-Johnston
Pier Luigi Zinzani
Tycel J. Phillips
Joseph Maly
Silvia Ferrari
Locke J. Bryan
Vincent Delwail
Sophie de Guibert
Monica Tani
Vivian Dai
Karin Havenith
Joseph Boni
Xiaomin He
Annette Ervin-Haynes
Carmelo Carlo-Stella
Show All
Source
Cite
Save
Citations (0)
On the Edge : The New Orientalism in American Advertising
2014
Vivian Dai
Show All
Source
Cite
Save
Citations (1)
1